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The ability of peforelin (l-GnRH-III) to stimulate follicular growth, FSH release, and estrus
in gilts after altrenogest treatment and in sows after weaning was investigated. In three
farrow-to-wean herds, with at least 600 sows and average production performance, 216
gilts, 335 primiparous, and 1299 pluriparous sows were randomly allocated to three
treatments: peforelin (M group: Maprelin), eCG (F group: Folligon), and physiological sa-
line solution (C group). Animals were treated 48 hours after their last altrenogest treat-
ment (gilts) or 24 hours after weaning (sows). The weaning-to-estrus interval, estrus
duration, estrus rate (ER), pregnancy rate, and total born (TB), live born, and stillborn (SB)
numbers were recorded and compared between treatments for the different parity groups
(gilts and primiparous and pluriparous sows). Follicle sizes were measured in represen-
tative animals from each group on the occasion of their last altrenogest treatment or at
weaning, and also on the occasions of their ﬁrst (FS1) and second (FS2) attempted in-
seminations. Blood samples were taken to determine FSH concentrations at weaning and 2
hours after injection, and progesterone concentrations 10 days after the ﬁrst insemination
attempt. The relative change in FSH concentrations was calculated. Signiﬁcant differences
were found for ER within 7 days of weaning in pluriparous sows (95%, 91%, and 90% for the
M, F, and C groups, respectively, P ¼ 0.005). Gilts in the F-group had high TB numbers,
and pluriparous sows in the M group had high SB numbers (TB gilts ¼ 13.6, 15.4, and 14.9
[P ¼ 0.02] and SB pluriparous sows ¼ 1.8, 1.4, and 1.7 [P ¼ 0.05] for the M, F, and C groups,
respectively). The M group had the highest FS1 (for gilts) and FS2 (for pluriparous sows)
values: FS1 ¼ 5.4, 4.9, and 4.9 mm [P ¼ 0.02] and FS2 ¼ 6.8, 5.3, and 6.3 mm [P ¼ 0.03] for
the M, F, and C groups, respectively. There were no signiﬁcant differences between the
different treatments within each parity group with respect to any of the other variables.
Overall, peforelin treatment had small but positive effects on the ER and follicle growth in
certain parity groups but did not seem to affect litter sizes or FSH and progesterone levels
in sows on the occasions of the corresponding examinations.
 2013 Elsevier Inc. All rights reserved.x: þ32 92 167 141.
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21. Introduction
Maintaining optimal reproductive performance is
essential for meeting economic targets in commercial pig
production. Management strategies, including accurate
feeding at different stages of breeding, batch farrowing,
Table 1
Characteristics of the three pig herds included in the study.
Characteristics Herd A Herd B Herd C
Number of sows per herd 1200 1700 600
Number of sows
included in study
627 685 633
Breed of sows Danbred  York PIC Topigs20
Batch-production
system for sows (weeks)
1 2 4
Lactation period (weeks) 3 3 3
Piglets weaned/sow/y 25.9 26.1 26.3
Average
weaning-to-insemination
interval (days)
7.0 7.1 7.8
Age of gilts at ﬁrst
insemination (days)
280 290 250
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the insemination facility are not always sufﬁcient to
meet farmers’ performance requirements. Pharmaceuti-
cals, that is, hormones, can be used to manipulate the
estrus cycle in swine, for example, to synchronize estrus
and ovulation within a herd, which can increase repro-
ductive performance [1]. In females that have undergone
an estrus synchronization program, it is possible to
inseminate multiple batches of sows within a short time
framed1 or 2 daysdwhich results in a relatively syn-
chronized onset of farrowing within these batches. These
procedures are increasingly important, especially in
herds where batch production systems for sows are used
or will be used.
Treatment with exogenous gonadotropins in sows
after weaning or in gilts after altrenogest treatment has
been used to stimulate follicular development and to
induce ovulation in prepuberal, cycling, lactating, and
anestrus sows [2]. It has also been shown to improve the
synchronization of estrus onset within batches [1,3,4]. In
addition, gonadotropins have been used to decrease the
weaning-to-estrus interval (WEI), which proved to be
particularly helpful in sows that were at a high risk of
reduced fertility during the post-weaning period, such as
ﬁrst parity sows [5] or animals experiencing seasonal
infertility problems [6].
The release of LH and, to a lesser extent, FSH from
the pituitary gland is governed by the hypothalamic
GnRH [1,2,7,8]. GnRH is therefore a key regulator of the
growth, maturation, and, ultimately, the ovulation of
follicles. Whereas LH secretion is dependent on GnRH,
FSH is not. Instead, the FSH levels are regulated by other
peptides, such as gonadal activins, inhibins, and folli-
statins [8–10]. Twenty years ago, Sower et al. [11] re-
ported for the ﬁrst time that there is another selective
FSH-releasing factor produced by the hypothalamus in
ﬁshdspeciﬁcally, the lamprey, Petromyzon marinus
(lamprey GnRH-III). This variant of GnRH was put for-
ward as a potential FSH-releasing factor. Numerous
subsequent in vivo and in vitro studies were conducted
in different species, yielding inconsistent results. On the
basis of in vitro and in vivo studies with rats, cows, and
barrows, treatment with l-GnRH-III induces increases in
the levels of FSH but not of LH [10,12–14]. However,
studies on mid-luteal intact cows [15] and barrows [16]
reported that l-GnRH-III only stimulates the release of
LH and does not affect FSH. Still other studies indicated
that treatment with 1-GnRH-III did not cause any in-
crease in the levels of either FSH or LH in rodent brain
tissues [17] or in gilts [1], but stimulated the secretion of
both gonadotropins in rat pituitary cells [18] and ovari-
ectomized cows [15]. To date, no studies have been
conducted to explore the inﬂuence of l-GnRH-III on the
secretion of the different reproductive hormones in gilts
and sows at the same time.
Recently, a German company, Veyx, launched the
product Maprelin, whose active substance is l-GnRH-III
(peforelin). This agent is marketed for the induction of
the estrous cycle in sows after weaning and in sexually
mature gilts, in animals that have undergone progesto-
gen therapy to inhibit the estrous cycle. Different studiesconducted in Germany have suggested that treatment
with peforelin (Maprelin, l-GnRH-III, Veyx-Pharma,
Schwarzenborn, Germany) has positive effects on estrus
induction in gilts and sows [19,20] and reduces the
interval between the animals’ most recent altrenogest
treatment and the onset of estrus in gilts [21,22]. It
may also decrease the negative effects of seasonal
infertility [19].
The purpose of the study reported herein was to
investigate the ability of peforelin to stimulate follicular
growth and estrus in gilts after altrenogest treatment
and in post-weaning sows, and to study its effects on
litter size in Belgian farrow-to-wean herds with average
production performance. In addition, FSH and proges-
terone (P4) levels in the studied animals were analyzed
to investigate the effects of l-GnRH-III on FSH release
and the ability of the CL to produce P4. The performance
of the peforelin-treated animals was compared with that
of a pregnant mare serum gonadotropin (ECG)-treated
group and an untreated control group.
2. Materials and methods
The study was conducted between January 2010 and
May 2011 and was approved by the Ethical Committee of
the Faculty of Veterinary Medicine of Ghent University
(approval: EC2010/035).2.1. Herd selection, study animals, and management practices
Three farrow-to-wean herds in the province of West
Flanders with at least 600 sows (600–1700) and an
average reproductive performance for the Belgian swine
industry were included in the study. Brieﬂy, the number
of weaned piglets/sow/year ranged from 23 to 27, and
on average, 85% to 95% of the sows reported estrus
within 7 days of weaning. More detailed information on
the farms is presented in Table 1.
In total, 1945 gilts and sows (average: 650 per herd)
were investigated during one reproductive cycle, starting
at the point of weaning for sows or from their most
recent altrenogest treatment for gilts, to their subse-
quent weaning (Table 1). Animals with clinical disease
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or pathological vaginal discharge, were not included.
Gilts had been treated with altrenogest (Regumate, MSD
Animal Health, Brussels, Belgium) for 18 days (20 mg per
gilt per day, administered orally) after having shown at
least one estrus. To ensure accurate dosing, gilts were
housed in individual stalls during altrenogest treatment.
Sows were weaned on Days 20 to 21 of lactation. One
day after the ﬁnal altrenogest treatment (gilts) or
weaning (sows), the animals were moved to a breeding
facility, with individual housing and a light schedule of
16 hours per day giving 250 lux, measured at the sows’
heads.
Estrus stimulation started on the ﬁrst day
post-weaning (pw) in sows or 48 hours after the last
altrenogest treatment in gilts (for the sake of conve-
nience and consistency, the day of the last altrenogest
treatment is henceforth referred to as the ﬁrst day
post-weaning or “pw”), using at least two teaser boars.
All animals were fed ad libitum with a gestation feed
from Day 1 pw until insemination. A supplement of 150
mg dextrose per day per animal was provided as a top
dressing. To further optimize estrus stimulation and
detection, supplemental boar noises were played to the
animals in herd A via a voice recorder, and herd C used a
Contact-O-Max (Ro-Main Europe, France), which is a
remote-controlled mobile unit with a boar inside.
Estrus detection was performed twice a day (am and
pm) from Day 4 pw onwards. The same artiﬁcial
insemination (AI) schedule was used in all three herds.
Brieﬂy, sows showing standing estrus on Day 4 pw in
the morning were inseminated 24 hours later, and those
showing estrus in the evening were inseminated 12
hours later. Sows showing standing estrus on Day 5
were inseminated 8 hours later, whereas those showing
estrus on Day 6 pw were inseminated immediately. Sows
that still showed estrus 12 hours after their ﬁrst round
of AI were inseminated a second time, and a third time
in the rare cases where standing estrus persisted for 24
hours. Single sire semen from boars of proven fertility
was purchased from a commercial AI center.
Pregnancy testing was performed by the herd veter-
inarian using ultrasound at 23 to 28 days of gestation
and again 2 weeks later. Gilts and sows that were found
to be pregnant at 23 to 28 days were moved to the
gestation unit. In herds A and B, pregnant females were
housed in groups, with the exception of gilts and sows
that had previously experienced reproductive problems
(e.g., repeat breeding) in herd A. In herd C, only gilts
were housed in groups, and weaned sows were housed
in individual stalls. In all three herds, animals were fed a
gestation diet ad libitum in the group housing-gestation
unit.
All of the participating herds used similar vaccination
schedules for their sows. Sows were vaccinated for
Parvovirus and Erysipelothrix rhusiopathiae (2 weeks
postpartum), Escherichia coli (2 weeks prepartum in herd
A), atrophic rhinitis (2 weeks prepartum in herds A and
C), Porcine Respiratory and Reproductive Syndrome virus
(four times a year in herds B and C), and, ﬁnally, Swine
Inﬂuenza Virus (three times a year in herd C).2.2. Experimental design
The study population was grouped into three age
categories: gilts and primiparous and pluriparous sows.
Within each age category, animals were randomly allo-
cated to one of three treatment groups before treatment:
peforelin (the M group), in which gilts and pluriparous
sows were treated with 150 mg peforelin, corresponding
to 2 mL of Maprelin based on the manufacturers’
documentation, and primiparous sows were treated with
37.5 mg peforelin, corresponding to 0.5 mL of Maprelin;
equine Chorion Gonadotropin (eCG; the F group) as a
positive control, in which animals were treated with
1000 IU eCG, corresponding to 1 mL of Folligon, MSD
Animal Health, Brussels, Belgium; and physiological
saline solution as a negative control (the C group), in
which animals were treated with 1 mL of physiologic
saline solution.
All treatments were applied via intramuscular injection
into the neck 24(1) hours pw (sows) or 48(1) hours
after their last altrenogest treatment (gilts). The entire
study, including estrus detection, AI, and the recording of
the different parameters, was conducted using a blinded
design.
2.3. Major parameters
2.3.1. Estrus and pregnancy
The measured variables were the estrus rate (ER, the
proportion of gilts and sows showing estrus), WEI (the
interval between the day of the last altrenogest treat-
ment for gilts or the day of weaning for sows and the
onset of estrus), estrus duration (ED, the interval be-
tween the detection of the ﬁrst and last standing estrus),
and pregnancy rate (PR, the proportion of pregnant an-
imals from the animals inseminated).
2.3.2. Litter size
The number of total born (TB), live born (LB), stillborn
(SB), and mummiﬁed (M) piglets was recorded for each
litter.
2.4. Minor parameters
For the minor parameters, 10 animals per age group
and per treatment group in each herd (i.e., 90 animals
per herd) were selected at random and individually
identiﬁed at weaning, that is, 24 hours before treatment
for sows or on the last day of altrenogest treatment for
gilts.
2.4.1. Follicle size
Ovary scanning was conducted according to the pro-
cedures described earlier [23]. The ovaries of the sows
were monitored using transabdominal ultrasound scans
performed with a sectorial probe (5 MHz, MS Multiscan
digital, MS Schippers, The Netherlands) to estimate the
average follicle size. Ultrasound scans were performed
twice daily, at intervals of w8 hours, at the time of
weaning or the last altrenogest treatment (FS0), and dur-
ing the ﬁrst (FS1) and second (FS2) insemination attempts.
Table 2
ER and WEI for the different treatment (M ¼ Maprelin, F ¼ Folligon, C ¼
control) and parity groups, in estrus within 7 days of weaning (7 d; SD).
Parity Group n ER 7 d (%) WEI 7 d  SD (d)
Gilts M 83 73 5.3  1.0
F 73 71 5.7  1.0
C 77 74 5.6  1.0
Primiparous M 129 88 4.7c  0.8
F 109 90 4.5d  0.9
C 108 90 4.7c  0.8
Pluriparous M 446 95a 4.5  0.8
F 432 91b 4.5  0.8
C 461 90b 4.5  0.8
a,b Within a speciﬁc parity group, differences between treatment
groups were statistically signiﬁcant (P  0.05).
c,d Within a speciﬁc parity group, differences between treatment groups
showed a tendency (P ¼ 0.07).
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ovulation had already occurred, that is, to detect the
presence of follicles with diameters in excess of 2 mm
following larger follicles, as well as to identify potential
abnormalities such as ovarian cysts, that is, cyst-like for-
mations with diameters of >15 mm. Where possible, four
(at minimum, two) clearly deﬁned follicles were measured
in the right ovary, after which the mean follicle size was
calculated to assess the follicular diameter. Ultrasound
testing was always performed by the same experienced
person (ﬁrst author).
2.4.2. FSH and P4 concentrations
Three blood samples for hormone analyses were
drawn by venopuncture from the “vena jugularis.”
Samples were collected immediately before treatment in
order to determine a baseline concentration of FSH; 2
hours (0.5) after treatment, in order to determine the
effect of l-GnRH-III on the release of FSH, and, ﬁnally, on
the 10th day after the ﬁrst AI attempt, to determine the
capability of the CL to produce P4. Samples were
transported to the Faculty of Veterinary Medicine (Ghent
University, Merelbeke, Belgium) and centrifuged for 10
minutes at 2.504  g at 4 C within 12 hours of
collection. The serum was then collected and stored
at 20 C until analysis.
For analysis, the serum was shipped in bulk to the
laboratory of the Faculty of Veterinary Medicine in Leipzig
(Germany). FSH concentrations were determined in the
ﬁrst two blood samples by RIA following the procedure
described by Kauffold et al. [24]. The limit of detection was
0.4 ng/mL, and the intra- and interassay coefﬁcients of
variation (CVs) were 6.4% and 10.6%, respectively. P4
analysis was performed using the third samples (i.e., those
collected 10 days after the ﬁrst AI attempt), as described
by Brüssow et al. [1]. The intra- and interassay CVs for
this procedure were 7.5% and 8.1% respectively, and its
lower limit of detection was 0.5 ng/mL.
The mean FSH levels before treatment for females
within the treatment and parity groups were used as
baseline concentrations, and the relative change in con-
centration between the post- and pretreatment periods
was used as the treatment response.
2.5. Statistical analysis
The number of animals in each age category (gilts,
primiparous, and pluriparous) was sufﬁcient to detect
differences of at least 5.0% in the ERs between the
groups with 95% conﬁdence, 80% power, and a standard
deviation of 3.1 (WinEpiscope 2.0) [25]. Data analysis
was conducted in a blinded manner. All statistical cal-
culations were performed using version 20.0 of the SPSS
software package (SPSS Inc., Chicago, IL, USA).
The normality of the data sets was tested using the
Kolmogorov-Smirnov test and the Shapiro-Wilk test. The
results for the different treatment groups were expressed
as arithmetic means and the corresponding SDs. For all
parameters, separate analyses were performed for animals
with a WEI 7 days after weaning and those with a WEI of
>7 days. Comparisons between the three treatment groupswere made for all animals and separately for the three
different parity groups. For all parameters, the effect of
parity and herd was signiﬁcant. Therefore, three different
analyses were performed per parity group and herd was
included in the statistical model. Multiple comparisons for
the parameters TB, LB, SB, M, and FS were performed using
ANOVA. Pairwise comparisons between groups were con-
ducted using the post hoc Bonferroni test. For parameters
with non-normal distributions (WEI, ED, FSH, and P4),
nonparametric tests were used. Cross-tabulations and the
Chi-squared test were used to detect differences between
the treatment groups with respect to the ER and PR pa-
rameters. The signiﬁcance threshold applied was P  0.05.
3. Results
Results for a total of 1918 animals were included in the
statistical analysis. Twenty-seven sows (1.4%) had incom-
plete records and were excluded from the analysis.3.1. Major parameters
3.1.1. Estrus and pregnancy
The ER 7 days and the WEI 7 days for the three
different treatment and parity groups are shown in
Table 2.
For pluriparous sows, the ER 7 days were signiﬁ-
cantly (P ¼ 0.005) higher in the M group (95%) than the
F (91%) or the C group (90%).
The WEI 7 days tended to be shorter in the F group
(4.5 days) than the C or M groups (4.7 days) in
primiparous sows (P ¼ 0.07). The WEI >7 days in gilts was
greater than 21 days in the M and C groups (P ¼ 0.05) and
also in the M and F groups for pluriparous sows (P ¼ 0.07).
For primiparous sows, the WEI >7 days value was greater
than 21 days in all the three treatment groups. There were
no signiﬁcant differences between any of the treatments
for each parity group with respect to their ED 7-day
values (mean ¼ 36.3  16.0, 39.6  14.1, and 43.0  14.9
hours for gilts, primiparous, and pluriparous sows,
respectively) nor with respect to their PR 7-day values
(mean ¼ 82%, 79%, 84% for gilts, primiparous, and pluri-
parous sows, respectively).
Table 4
Follicle size (mean  SD; in mm) at weaning (FS0) and at ﬁrst (FS1) and
second insemination (FS2) for the different treatment (M ¼Maprelin, F ¼
Folligon, C ¼ control) and parity groups.
Parity Group n FS0  SD FS1  SD FS2  SD
Gilts M 40 2.6  0.8 5.4b  1.0 5.7  1.8
F 20 2.5  0.8 4.9a  0.6 5.0  1.7
C 32 2.5  1.1 4.9a  1.2 5.9  1.7
Primiparous M 35 2.9  0.8 5.5  1.1 6.2  2.0
F 23 2.8  1.4 5.7  1.8 6.2  1.9
C 30 3.1  1.0 5.6  1.3 5.8  2.5
Pluriparous M 27 3.0  1.1 5.5  1.3 6.8a  2.3
F 34 3.1  1.1 5.6  1.6 5.3b  2.5
C 34 3.4  1.1 5.4  1.3 6.3a,b  2.3
a,b Within a speciﬁc parity group, differences between treatment
groups were statistically signiﬁcant (P  0.05).
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Table 3 presents the TB, LB, and SB numbers for the
different parity and treatment groups.
The TB number was signiﬁcantly higher in the F
group (15.4 piglets) than the M group (13.6 piglets) in
gilts (P ¼ 0.02). In primiparous sows, the TB number for
the F group tended to be greater than in the C group
(15.4 vs. 14.1, respectively, P ¼ 0.09).
The SB number was higher in the M group (1.8 pig-
lets) than in the F group (1.4 piglets) in pluriparous sows
(P ¼ 0.05).
The number of M per litter was similar for all treat-
ment groups and for all parity groups (0.2  0.5
mummies, P > 0.05).
3.2. Minor parameters
3.2.1. Follicle size
The percentage of sows that had no follicles with
diameters above 2 mm at weaning and still had only
small follicles on their ﬁrst and second AI attempts (i.e.,
those that experienced no post-weaning follicular
growth or had already ovulated) was 0%, 8%, and 23%,
respectively, over all animals and all treatments. There
were no signiﬁcant differences between the treatment
groups with respect to these variables. Polycystic ovaries
were found in three sows at ﬁrst AI, one from the F
group and two from the C group. These sows were
excluded from subsequent analyses.
The FS0, FS1, and FS2 results are presented in Table 4.
The mean FS1 value was signiﬁcantly larger in the M
group (5.4 mm) than the F (4.9 mm) or C groups (4.9
mm) for gilts (P ¼ 0.02). The mean FS2 value was
signiﬁcantly larger in the M group (6.8 mm) than the F
group (5.3 mm) in pluriparous sows (P ¼ 0.03).
3.2.2. FSH and P4 concentrations
There was no signiﬁcant difference between the
treatment groups with respect to the relative change
in mean FSH levels over the studied period (0.04 
0.43, 0.19  1.09, and 0.04  0.66 mg/L for gilts and
primiparous and pluriparous sows, respectively). There
was no increase in FSH levels following treatment in
either of the treatment groups.Table 3
The number of TB, LB, and SB piglets for the different treatment (M ¼
Maprelin, F ¼ Folligon, C ¼ control) and parity groups (SD).
Parity Group n TB  SD LB  SD SB  SD
Gilts M 49 13.6  3.5b 12.8  3.2 0.7  1.1
F 42 15.4  2.4a 14.2  2.5 1.0  1.3
C 48 14.9  2.9a,b 13.9  3.6 0.9  1.9
Primiparous M 90 14.7  3.6c,d 13.5  3.7 1.1  2.0
F 76 15.4  3.6d 14.1  3.6 1.3  2.1
C 74 14.1  3.3c 12.9  3.7 1.0  1.5
Pluriparous M 347 15.4  3.5 13.5  3.3 1.8  2.0b
F 332 14.8  3.9 13.2  3.5 1.4  1.9a
C 341 15.0  3.9 13.2  3.6 1.7  2.2a,b
a,b Within a speciﬁc parity group, differences between treatment
groups were statistically signiﬁcant (P  0.05).
c,d Within a speciﬁc parity group, differences between treatment groups
showed a tendency (P ¼ 0.09).The mean P4 levels in the F group (15.24 ng/mL) ten-
ded to be lower than those in the M (17.86 ng/mL) and C
(20.50 ng/mL) groups for primiparous sows (P ¼ 0.07). No
signiﬁcant differences were observed in either gilts or
pluriparous sows (19.95  6.43 and 17.97  5.68 ng/mL for
gilts and pluriparous sows, respectively).4. Discussion
This study was conducted to determine the effects of
peforelin, that is, synthetic l-GnRH-III, on the reproductive
capabilities of gilts after altrenogest treatment and post-
weaning sows in commercial Belgian pig herds. All herds
had an average to suboptimal reproductive performance on
the basis of recent benchmarking data for Belgian and
Dutch farms (PR ¼ 88%, WEI ¼ 5.6, and weaned piglets/
sows/year ¼ 28.5, Agrovision Herd monitoring 2011, Cerco
Soft N.V., Oudenaarde, Belgium). In general, the differences
between the treatment groups were relatively small for all
of the studied variables. Statistically signiﬁcant differences
were only observed for the ER in pluriparous sows, the
follicle size at AI for gilts and pluriparous sows, and the
total numbers of born and SB piglets in gilts and pluri-
parous sows, respectively.
Signiﬁcantly more pluriparous sows in the peforelin
treatment group reported estrus within 7 days of weaning
thanwas the case for the negative control group or the eCG
treatment group. This is important from an economical and
practical perspective because it reduces the number of
nonproductive days. Assuming a cost of V3.5 per sow per
nonproductive day [26] and an average treatment cost of
V3.2 per treated sow for peforelin, the elimination of even
one nonproductive day would be economically beneﬁcial
(V0.3 proﬁt per sow per day). Because peforelin treatment
increased the number of sows in estrus within 7 days of
weaning by 5% in herds with 650 sows on average, it would
save the farmer almost V10 per day (32.5 sows * V0.3).
Peforelin treatment can also be easily incorporated into
sow batch management systems. Sows that do not enter
estrus within a set time frame in a batch production system
are good candidates for culling, but are frequently given
another chance in order to limit the replacement rate.
However, if the proportion of sows that do not enter estrus
can be decreased sufﬁciently, as was the case for
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sows can safely be culled and replaced. It is not clear why
this effect was only seen in pluriparous sows. Engl et al.
[19,20,22] observed an increase in ER for all parity groups
treated with peforelin (relative to eCG treatment). It is
worth mentioning that according to the participating pro-
ducers, the gilts treated with peforelin had the best per-
formance in terms of ER (personal communication).
However, the measured ER data do not support this
observation. The physical body condition of the sows is
very important for the reproductive cycle [27,28], and
major back fat losses during lactation may negatively in-
ﬂuence the outcome of their estrous performance. How-
ever, it is unlikely that differences in metabolic stage alone
can explain the aforementioned discrepancies in the ER
data, because there were no differences in back fat loss
between the studied groups (data not shown).
There were no differences between the treatment
groups with respect to ED and WEI, with one exception:
primiparous sows treated with eCG tended to have shorter
WEI values. This is consistent with the results of Engl [21]
and Engl et al. [20], and may occur because eCG exhibits
both LH- and FSH-like activities [29]; LH stimulates the
growth of follicles from 4 mm to preovulatory size [30],
which in turn shortens the follicular phase and thus the
WEI [31].
The PR of the sows examined in this work was w80%
and was lower than the PR obtained before the study
(85%). This may indicate that the selected herds did not
have optimal reproductive performance, because the
typical PR target values are 90% ormore [32]. The reason for
the lower PR in this case is not clear. However, in 23% of the
studied sows, no follicles were seen at the second AI,
indicating that they had already ovulated. Therefore, it is
possible that the timing of the insemination was not
optimal in (some of) these sows [33] and that the relatively
low PR values in the study were due to the use of an
inappropriate insemination scheme.
The lack of signiﬁcant differences with respect to TB
between the control and treatment groups could indicate
the safety of the products, because they did not induce
superovulation. This would be consistent with the results
of Manjarin et al. [34] and Patterson et al. [5]. More
piglets were born to gilts and primiparous sows treated
with PMSG than to untreated animals or animals injected
with peforelin. According to Brüssow and Wähner [35],
PMSG is the only agent that can stimulate sufﬁcient
ovulatory follicles to produce large viable litters. How-
ever, do Lago et al. [36] and Martinat-Botté et al. [3]
found that PMSG treatment increased the ovulation
rate, but also had a negative inﬂuence on embryonic
viability, probably because it increased follicular hetero-
geneity in the preovulatory pool and caused the asyn-
chronous development of embryos [37,38].
Previous studies [10,12–14] have shown that l-GnRH-III
treatment increases FSH levels. Increased levels of FSH
during the follicular phase increase follicular size [39,40]
and the size of the CL [38,41], which lead to elevated P4
levels [42].
The largest follicles at insemination were observed in
gilts and pluriparous sows treated with peforelin. This is inkeeping with the results of Engl [21], who suggested that
peforelin promotes the release of FSH [10,12–14]. Surpris-
ingly, FSH levels did not increase signiﬁcantly following
treatment in any group examined in this work, including
the peforelin group. It is possible that the animals’ FSH
levels increased rapidly after treatment but then returned
to the baseline level within 2 hours of injection. This would
be consistent with the report of Kauffold et al. [10], who
observed that FSH levels peaked at 205% of their initial
value 1 hour after peforelin treatment in barrows. Dees
et al. [14] found that the peak response occurred within 15
minutes of treatment and that basal FSH levels were
restored 1.5 hours after stimulation with l-GnRH-III in
cows. The results obtained in this work are consistent with
those reported by Brüssow et al. [1] and Barretero-
Hernandez et al. [16], who used l-GnRH-III in either gilts
or barrows and found no evidence of FSH-releasing activity.
It is therefore not clear why peforelin-treated animals had
larger follicles than those seen in other treatment groups at
ﬁrst AI, nor can the results of this study explain the dif-
ferences between the results of previous studies with
respect to the FSH-releasing activity of l-GnRH-III. It may be
that l-GnRH-III acts locally at the ovarian level, as has been
shown for GnRH in rats [43].
Wientjes et al. [42] reported that there is a positive
relationship between follicle size and the size andweight of
the CL, indicating that larger follicles develop into larger CL,
which then produce more P4. Although treatment with
peforelin increased follicle diameter in this work, this did
not signiﬁcantly increase P4 levels. Suboptimal LH surge
levels could potentially cause inadequate luteinization of
the ovulated follicles and therefore reduce plasma P4 levels
and increasing embryo mortality [44]. Because LH was not
measured in this work, no conclusion can be drawn on this
matter. However, the P4 levels in pregnant sows were
signiﬁcantly higher than in their nonpregnant counterparts
(P ¼ 0.03, data not shown), indicating that the timing of
blood sampling was correct and that the lack of differences
between groups with respect to their P4 levels was not due
to inappropriate sampling.
The trial was conducted in three different herds, with
similar reproductive histories. The management pro-
cedures applied to the three herds were all relatively
similar in terms of weaning, insemination, housing, and
feeding regimes. In addition, seasonal effects can be ruled
out because the study was conducted over a period of 17
months. Nevertheless, a signiﬁcant herd effect was
observed for all of the studied parameters; this may have
been related to the breed of the sows. The study was con-
ducted in a double-blinded fashion because estrus detec-
tionwas performed by the farmers whowere blinded to the
applied treatments, and the statistical analysis was per-
formed by an independent statistician.
5. Conclusion
The results presented herein indicate that treatment
with peforelin caused a signiﬁcant increase in the number
of pluriparous sows in estrus within 7 days of weaning.
Peforelin also seems to have a positive effect on follicle
growth in gilts and pluriparous sows. If the number of
E. de Jong et al. / Theriogenology 80 (2013) 870–877876sows that have not entered estrus within 7 days can be
minimized, for example, by treatment with peforelin,
culling decisions become easier to make and losses due to
nonproductive days are minimized, which can save
farmers up to V10 per day. However, the administration of
hormonal products cannot be used as a substitute for
adequate management.
Further studies on the FSH-releasing activity of
l-GnRH-III are warranted because the available data on
this topic are highly inconsistent; in almost half of the
previous studies, there was no increase in FSH levels
following 1-GnRH-III treatment.
The inﬂuence of peforelin on the birth weight of the
piglets produced by gilts and sows and the performance of
their subsequent litters will be described in a second paper.
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